BioRestorative Therapies shareholders elect directors, approve stock plan amendment, ratify auditor, okay exec pay

BioRestorative Therapies, Inc.

Elected Francisco Silva (1.59M for) and David Rosa (1.47M for) as Class II directors; ~3.33M broker non-votes.
Approved amendment to 2021 Stock Incentive Plan boosting authorized shares from 6.85M to 9.85M (1.34M for, 289K against).
Ratified CBIZ CPAs as independent auditor for FY2025: 4.72M for, 271K against, 4,864 abstentions.
Advisory vote on executive compensation passed: 1.54M for, 107K against, 19,855 abstentions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.